TerrAscend (TSNDF) Net Cash Flow Growth (3y) (2024 - 2026)
TerrAscend (TSNDF) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | -62.71% |
| 10 | TerrAscend | 168.49 Mn | 168.02 Mn | 34.60 Mn | -39.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.87% |
| Dec 31, 2025 | 66.04% |
| Sep 30, 2025 | 36.28% |
| Jun 30, 2025 | 48.17% |
| Mar 31, 2025 | -25.43% |
| Dec 31, 2024 | 41.04% |
| Sep 30, 2024 | 85.32% |
| Jun 30, 2024 | 29.26% |
| Mar 31, 2024 | -89.09% |